Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Remitly Global Inc (RELY) vs Tenet Healthcare Corporation (THC) Price & Performance

Remitly Global IncTrade
Tenet Healthcare CorporationTrade

Price performance (Past 24H)

Key statistics

Remitly Global Inc vs Tenet Healthcare Corporation — how do they compare? Remitly Global Inc trades at $22.89 (market cap $4.85B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Tenet Healthcare Corporation is far larger — about 4.3× Remitly Global Inc's market cap, and Tenet Healthcare Corporation is more actively traded (455,764 versus 2,599,081). Which is the better fit depends on your goals — on Pluang, investors hold Remitly Global Inc for 53 Days and Tenet Healthcare Corporation for 15 Days on average.

RELYTHC
Market Cap
$4.85B$20.92B
Volume
2,599,081455,764
Sector
TechnologyHealth
52-Week High
$26.92$280.77
52-Week Low
$12.20$161.37
Typical Hold Time
53 Days15 Days
Enterprise Value
$4.22B$32.00B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Remitly Global Inc

RELY trades at $23.52, up 1.38% today, with a bullish technical signal from moving averages. The company shows strong fundamental momentum, with revenue growing from $654M in 2022 to $1.64B in 2025 and turning profitable with a net income of $67.93M. Recent Q2 2026 earnings beat expectations with EPS of $0.93 versus $0.12 expected, and active customers surpassed 10 million. Positive cash flow trends and a partnership with Etsy highlight operational strength and growth initiatives.

The outlook for RELY is positive, supported by accelerating revenue growth, expanding profit margins, and strong analyst consensus with a $30.50 price target. Key risks include reliance on continued customer expansion, competitive pressures in digital payments, and market volatility. The stock presents an opportunity for growth investors given its earnings beats and bullish institutional sentiment, though execution on growth targets remains critical.

Tenet Healthcare Corporation

Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.

THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RELY
15% Buy85% Sell
Avg holding period · 53 Days
THC

No sentiment data available yet.

About Remitly Global Inc

Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.

Read more on RELY →

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC →